Clinical Trial

Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction

Name: Safety Follow-up Study of Cellgram-ED in Post-Radical Prostatectomy Erectile Dysfunction — clinical trial record (NCT07431008)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Cellgram-ED

Recruiting

View on ClinicalTrials.gov →

Summary

This phase II clinical trial with safety follow-up is designed to evaluate the efficacy and safety of Cellgram-ED (autologous bone marrow-derived mesenchymal stem cells) administered via intracavernous injection in patients with erectile dysfunction after radical prostatectomy.

Trial Details

NCT Number	NCT07431008
Lead Sponsor	Pharmicell Co., Ltd.
Conditions	Erectile Dysfunction
Enrollment	32 participants
Start Date	2024-12-26
Primary Completion	2030-01-10 (estimated)
Study Completion	2030-01-10 (estimated)
Updated on ClinicalTrials.gov	2026-02-24